Ventral midbrain dopamine (DA) is unambiguously involved in motivation and behavioral arousal, yet the contributions of other DA populations to these processes are poorly understood. Here, we demonstrate that the dorsal raphe nucleus DA neurons are critical modulators of behavioral arousal and sleepwake patterning. Using simultaneous fiber photometry and polysomnography, we observed time-delineated dorsal raphe nucleus dopaminergic (DRN DA ) activity upon exposure to arousal-evoking salient cues, irrespective of their hedonic valence. We also observed broader fluctuations of DRN DA activity across sleep-wake cycles with highest activity during wakefulness. Both endogenous DRN DA activity and optogenetically driven DRN DA activity were associated with waking from sleep, with DA signal strength predictive of wake duration. Conversely, chemogenetic inhibition opposed wakefulness and promoted NREM sleep, even in the face of salient stimuli. Therefore, the DRN DA population is a critical contributor to wake-promoting pathways and is capable of modulating sleep-wake states according to the outside environment, wherein the perception of salient stimuli prompts vigilance and arousal.
Correspondence viviana@caltech.edu In Brief
Cho et al. demonstrate that dorsal raphe nucleus dopaminergic (DRN DA ) activity escalates in response to salient stimuli irrespective of valence, correlates with sleep-wake states, and can bidirectionally modulate arousal.
INTRODUCTION
In mammals, behavioral arousal fluctuates as inputs are received from both the external environment (e.g., food availability, predator threat) and internal milieu (e.g., hunger, mating drive, homeostatic sleep demand) (Garey et al., 2003; Brown et al., 2012) . While the neural circuits that encode these individual stimuli can be highly stimulus specific or tuned to a specific valence (positive or negative), their activation often promotes more general effects on arousal and electrocortical wakefulness through diverse wake-promoting neurons (Aston- Jones and Bloom, 1981; Szymusiak and McGinty, 2008) . Akin to how the noradrenergic (NA) neurons of the locus coeruleus (LC) regulate circadian sleep-wake cycling (Takahashi et al., 2010) and promote vigilance during wake (Aston- Jones and Bloom, 1981) , multiple neural circuits play roles in electrocortical wakefulness and behavioral arousal to motivationally relevant situations, including cholinergic neurons of the pons and basal forebrain (Jones, 1991; Xu et al., 2015; Pinto et al., 2013) , the corticotrophinreleasing hormone (CRH) and hypocretin (orexin) neuropeptide systems (Sakurai et al., 1998; Winsky-Sommerer et al., 2005) , and the mesolimbic dopamine (DA) system Taylor et al., 2016) .
Several lines of basic research and clinical observations converge upon DA as a crucial modulator of wake drive, but the neuroanatomical underpinnings have resisted detailed characterization. For example, persistent elevation of DA tone via pharmacology (i.e., amphetamine [Daberkow et al., 2013] , modafinil [Qu et al., 2008] ) or genetic ablation of the dopamine transporter gene (Slc6a3) (Wisor et al., 2001 ) is associated with behavioral arousal, but these manipulations are diffuse and brain-wide rather than localized to a certain region. Recent work has revealed a role for ventral tegmental area (VTA) DA neurons in electrocortical arousal and sleep-wake patterning Taylor et al., 2016) , which complements its long-standing role in behavioral arousal to motivationally relevant stimuli (Cohen et al., 2012; Lammel et al., 2014; Matsumoto and Hikosaka, 2009 ). In contrast, diminished DA signaling from the substantia nigra pars compacta (SNc) is associated with insomnia, a major symptom in Parkinson's disease (Gjerstad et al., 2007) . Considering the functional (Morales and Margolis, 2017) , genetic (Poulin et al., 2014) , and anatomical (Lammel et al., 2011 (Lammel et al., , 2012 Margolis et al., 2008) heterogeneity of midbrain DA neurons, distinct DA subgroups may exert diverging effects on sleep-wake regulation.
Previously, a small population of DA neurons ($1,000 cells in rats) in the dorsal raphe nucleus (DRN; or ''A10 dc'' or ''ventral/ ventrolateral periaqueductal gray''; herein referred to as the DRN DA ) (Hokfelt et al., 1984; Descarries et al., 1986 ; Dougalis cues and whether this valuation is predictive of the corresponding behavioral response. Contrary to VTA DA -driven reward circuits, optogenetic activation of DRN DA neurons fails to reinforce operant responding (McDevitt et al., 2014) but instead conveys a negative affective state and promotes social seeking via a negative reinforcement mechanism (Matthews et al., 2016) . Given these seemingly disparate roles of DRN DA cells, namely to promote wakefulness (Lu et al., 2006) and encode a ''loneliness-like'' state (Matthews et al., 2016) , we hypothesized that DRN DA neurons may signal arousal on a more general level, including awakening from sleep, maintenance of wakefulness, and promoting arousal in response to behaviorally relevant cues.
Here, we performed longitudinal monitoring of DRN DA activity by calcium imaging via fiber photometry (Gunaydin et al., 2014) and of sleep-wake states via electroencephalography (EEG) and electromyography (EMG) recordings, in conjunction with optogenetics and chemogenetics for reversible, spatially specific control of neural activity (Rajasethupathy et al., 2016; Urban and Roth, 2015) . We found that DRN DA neurons are wake-active, showing higher population activity during wakefulness over sleep states, and that endogenous DRN DA activity correlates with state transitions and with external stimulus-driven behaviors. Furthermore, reversible and bi-directional manipulations of DRN DA firing support the sufficiency and necessity of these neurons in promoting vigilance and arousal. Taken together, our results provide evidence that DRN DA pathways provide a circuit for modulating behavioral states and salience-induced arousal in mammals.
RESULTS

DRN
DA Neurons Are Activated by Arousal-Provoking
Salient Cues
To investigate the natural dynamics of DRN DA neurons during awake-behaving states, we monitored DRN DA population activity in subjects exposed to a diverse array of salient stimuli and environmental settings. In vivo activity of DRN DA neurons was recorded using fiber photometry (Gunaydin et al., 2014) , which can measure bulk Ca 2+ -dependent fluorescence of GCaMP6, a genetically encoded calcium indicator (Chen et al., 2013) , through a single optical fiber positioned in deep brain structures (Figures S1A, S1G, and S1H). Our photometry setup utilized a 490 nm beam to activate Ca 2+ -dependent GCaMP6 fluorescence, as well as a 405 nm beam to image an isosbestic reference signal, which compensates for photo-bleaching and movement-related artifacts (Lerner et al., 2015) . For specific targeting of DRN DA neurons, we stereotaxically injected an adenoassociated virus (AAV) encoding GCaMP6f in a Cre-dependent manner (AAV5-Syn-FLEX-GCaMP6f) into the DRN of tyrosine hydroxylase (TH)::IRES-Cre mice (Figures 1A and 1B) . Control animals were injected with AAV encoding the fluorescent marker EGFP (AAV5-hSyn-DIO-EGFP). An optical fiber was implanted over the DRN to acquire population fluorescence emitted from DRN DA neurons (Figures 1A and S1A) . We confirmed that GCaMP6f-expressing neurons emitted dynamic fluorescence fluctuations, while EGFP-expressing cells showed minimal fluorescence variation (Figures S1B and S1C).
We quantified the efficiency and specificity of GCaMP6f+ neurons in the DRN of TH-Cre mice. Transfection was highly efficient (94.2%, n = 407/432 neurons). Similar to previous reports that used the identical mouse line or others targeting TH or the Slc6a3 promoter (Matthews et al., 2016) , 74.9% (n = 407/543) of GCaMP6f+ neurons were co-localized with TH in the DRN. These neurons are not noradrenergic, as they lack dopamine beta-hydroxylase, which converts dopamine to norepinephrine (Nagatsu et al., 1979) . Importantly, GCaMP6f+ or TH+ neurons never overlapped with serotonergic neurons (Figures 1B and S1D; Lu et al., 2006; Matthews et al., 2016) , a major population in the DRN that is hypothesized to regulate arousal states (Jouvet, 1999) . It is possible that GCaMP6f+/THÀ neurons may express TH at a level below immunohistochemical detection limit but sufficient to drive Cre expression.
We first tested DRN DA-GCaMP6f mice in a social interaction paradigm, in which physical contact with conspecifics after social isolation has been demonstrated to activate DRN DA neurons (Matthews et al., 2016) . We observed the robust activation of DRN DA neurons in single-housed male DRN DA-GCaMP6f mice when they first interacted with female intruders ( Figures 1C  and 1D ). Similar activation was observed with juvenile mice (Figure S2A ; Movie S1; Matthews et al., 2016) and also when they displayed aggressive behavior toward adult male intruders (Figure S2B Figures 1G and 1H ), air puffs ( Figure S2C ), or motivated responding (mobility/struggling) in tail suspension tests (Figure S2D) and during investigation of predator odor TMT (component of fox urine; Figure S2E ). Furthermore, they showed sustained activation when subjects were physically restrained ( Figure S2F ). In contrast, DRN DA activity showed minimal change when mice interacted with novel or familiar objects ( Figures 1I-1L , first encounters), which are less salient than social targets, food, or aversive cues. Indeed, DRN DA activation during female interaction, chocolate consumption, and footshock was significantly larger than that during object investigation ( Figure 1M ). Furthermore, the second and third bouts of female interaction and aggressive behavior continued to provoke a significant elevation in DRN DA activity, whereas it remained relatively unchanged from baseline with repeated novel object encounters, suggesting rapid habituation toward physically salient but motivationally neutral cues ( Figures S2G-S2I ). These findings did not vary with subject social history, as similar patterns of DRN DA activation were seen in group-housed mice ( Figures S2J-S2L ). Furthermore, DRN DA neuronal activation was not correlated with locomotion, which argues against the observed DRN DA activity resulting from the motor response alone ( Figures S2M-S2O ). Taken together, these findings suggest that DRN DA neurons are activated by a broad array of arousal-provoking stimuli, paralleling animals' heightened environmental awareness that accompanies exposure to such motivationally salient stimuli. paired t test, t 6 = 11.97, ***p < 0.001).
(E) Chocolate consumption by a DRN DA-GCaMP6f mouse increased DRN DA activity; representative recording.
(F) Left: DRN DA activity was increased upon chocolate consumption. Right: AUC quantification during consumption (0-5 s) compared with baseline (À5 to 0 s)
shows that food consumption is associated with significant fluorescence increase (n = 7 DRN DA-GCaMP6f mice; paired t test, t 6 = 4.273, **p < 0.01).
(G) Electric footshocks (0.25 mA, 1 s) were delivered; representative DRN DA trace during two consecutive footshocks.
(H) Left: footshock induced phasic DRN DA activation. Right: DRN DA activity after footshock (0-5 s) was significantly increased relative to baseline (À5 to 0 s) (n = 7 DRN DA-GCaMP6f mice; paired t test, t 6 = 5.763, **p < 0.01).
(I) DRN DA-GCaMP6f mouse was allowed to interact with a novel object; representative recording during interactions.
(J) Left: first interaction of a novel object was associated with DRN DA activity increase. Right: DRN DA activity after first interaction (0-5 s) was significantly increased relative to baseline (À5 to 0 s) (n = 7 DRN DA-GCaMP6f mice; paired t test, t 6 = 3.614, *p < 0.05).
(K) A familiar object was introduced; representative DRN DA trace with interaction bouts.
(L) Left: first interaction bout was not associated with any change in DRN DA fluorescence. Right: there was no change in DRN DA activity across familiar object interaction (n = 7 DRN DA-GCaMP6f mice; paired t test, t 6 = 2.205, p > 0.05).
(M) Peak DRN DA fluorescence values during female interaction, chocolate consumption, and electric footshocks were significantly higher than those during novel and familiar object interaction (n = 7 DRN DA-GCaMP6f mice; one-way ANOVA, F 4,30 = 22.77, p < 0.0001, Bonferroni post hoc analysis, ***p < 0.001).
Data represent mean ± SEM. (Matthews et al., 2016) . It seems plausible that DRN DA neurons convey more generalized arousal signals across broad temporal scales, especially given that chemogenetic activation promotes analgesia (Li et al., 2016) and selective lesion causes hypersomnia (Lu et al., 2006) . To test this hypothesis, we prepared TH-Cre mice for simultaneous and synchronized recording of DRN DA-GCaMP6s fluorescence (AAV5-Syn-FLEX-GCaMP6s, EGFP for control animals; DRN optical fiber insertion; Figures 2A and 2B ) and polysomnography signals (implantation of EEG electrodes and EMG wires; Figure 2A ). Sleep-wake states, which were manually classified in 5 s windows based on the visual and spectral characteristics of the EEG/EMG signals, were correlated to fluctuations in DRN DA population activity (Figures 2C and S3A) . Variations in fluorescent signal were absent in control DRN DA-EGFP mice (Figures 2D and S3B) , and viral delivery of transgenes (here and in all subsequent experiments) did not alter the basic sleep-wake architecture (Figures S1E and S1F).
To record DRN DA activity over many episodes of distinct sleep-wake states, we collected fiber photometry and EEG/ EMG across the entire light (inactive) phase ( Figure 2E ). DRN DA-GCaMP6s mice showed normal EEG spectral characteristics and sleep-wake patterns, even in the presence of GCaMP6s excitation light ( Figures S3C and S3D ). Over long recording sessions, GCaMP6s bleaching was observed, but it could be effectively removed by subtracting the linearly scaled control signal from 405 nm excitation ( Figure S3E ). To examine the correlation of DRN DA activity with sleep-wake states, we calculated the area under the curve (AUC) for non-overlapping 5 s windows of photometry data during each state as an index of the estimated DRN DA population firing rate ( Figure 2F ). AUC values were significantly higher during wakefulness ( Figure 2G ). For further characterization, Ca 2+ peak events were detected (Figure S3F) , and their quantitative features were compared across states. The peak amplitude and summed AUC values of detected events were highest during wakefulness, but there was no significant difference in their frequency or duration across distinct states ( Figures S3G-S3J ). Altogether, these results suggest that DRN DA neurons are wake-active and that their activity profile correlates with arousal states. To examine the temporal dynamics of DRN DA activity during each state, we normalized the variable durations of sleep-wake states to a unit-less time from 0 (onset) to 1 (offset) and accordingly down-sampled the normalized photometry traces. During wakefulness, DRN DA population fluorescence peaked soon after wake onset and gradually decreased toward wake offset (Figure 2H) . Indeed, the DRN DA activity at the early 20 th percentile of a wake episode was significantly larger than at the late 20 th percentile ( Figure 2I ). In contrast, DRN DA activity was continuously suppressed during NREM sleep and showed minimal variations during REM sleep ( Figure 2H ). We additionally verified that wake episodes whose durations were similar to sleep episodes demonstrated similar dynamics ( Figure S3K) Figure 3A ; when wake duration >60 s). There was no significant fluorescence change at REM-to-wake transitions ( Figure 3B ; when wake duration >60 s). Conversely, DRN DA activity decreased when animals fell asleep ( Figure 3C ). We also observed a gradual increase of DRN DA activity across NREM-to-REM transitions (Figure 3D) . When a brief period of wake (<15 s) intervened in transition from REM to NREM, DRN DA activity exhibited a corresponding decrease across the brief wake and NREM onset ( Figure S3L Figures 4A and 4B ). ChR2-eYFP expression was limited to the DRN and caudal linear nucleus, and never found in retrorubral field or VTA ( Figures S4N and S4O ). To avoid potential ceiling effects, we applied optogenetic stimulation to DRN DA neurons during the light phase ( Figure 4C ). As endogenous firing characteristics of DRN DA cells are unknown (one neuron reported by juxtacellular recording [Schweimer and Ungless, 2010 ]), we used stimulus parameters commonly adopted for photoactivation of ventral midbrain DA neurons (Tsai et al., 2009) applied both phasic (a train of ten 30 Hz pulses, 10 ms pulse width, every 5 s) and tonic (continuous 2 Hz pulses, 10 ms pulse width) stimulation patterns ( Figures 4C and S4D ). These specific parameters were designed to expose subjects to the same total number of light pulses with distinct temporal structures. We verified that DRN DA neurons were capable of faithfully following phasic pulse trains in whole-cell patch clamp recordings ( Figure S4A ). Two minutes of phasic stimulation caused immediate transitions to and maintenance of wakefulness from both NREM and We next sought to examine the effect of longer, sustained activation of DRN DA neurons on behavioral states. A 1 hr epoch of phasic stimulation was applied 4 hr into the subject's light phase when sleep pressure is high. Photostimulation resulted in a net increase in time awake relative to unstimulated epochs, due to the extension of wake episodes (Figures 4L and 4M) . Spectral analysis revealed that delta (0.5-4 Hz) power was significantly diminished while high-frequency (40-100 Hz) activity was enhanced in ChR2-expressing mice ( Figures 4N-4P ). This spectral change from DRN DA activation could not be attributed to increased locomotion, which can also affect cortical activity and arousal (Vinck et al., 2015) , because optogenetic manipulations did not affect locomotion in either the light or dark phase (open field test; Figure S4L ). Moreover, the sustained increase in wakefulness from DRN DA activation was directly mediated by DA, as systemic administration of D1 and D2 receptor antagonists (SCH-23390 and eticlopride, respectively, 1 mg/kg) prior to stimulation abolished the wake-promoting effect of phasic stimulation in DRN DA-ChR2 mice but caused no overall effect in control mice ( Figures S4J-S4K ).
In sum, phasic stimulation of DRN DA neurons can affect sleepwake state patterning and promote arousal by inducing immediate sleep-to-wake transitions and prolonging wake duration. DRN DA activity also causes electrocortical arousal, bi-directionally modulating low-and high-frequency rhythms across both minutes-short and hour-long temporal scales.
Chemogenetic Inhibition of DRN DA Neurons Reduces Wakefulness
To interrogate the necessity of DRN DA signaling for wake maintenance, we used a chemogenetic (Urban and Roth, 2015) approach to reversibly inhibit DRN DA activity during polysomnographic recordings ( Figure 5A ). Here, DRN DA cell recruitment via expression of the inhibitory DREADD (AAV2-hSyn-DIO-hM4Di-mCherry; Figures 5A and 5B) rather than the analogous opsin is not limited to light spread from optical fibers, and long-term suppression of DRN DA activity carries no potential for phototoxicity. We confirmed with ex vivo whole-cell patch-clamp recordings that bath application of 1 mM clozapine-N-oxide (CNO) reversibly reduced the firing of hM4Di-expressing DRN DA neurons via hyperpolarization but showed no effect on EGFP-positive cells in control mice ( Figures S5B-S5E ). We also verified that the hM4Di vector was not anterogradely or retrogradely transported from the DRN to other TH+ neurons (across a 4-week window; Figures S5F-S5I), some of which have been shown to have reciprocal connections (Lu et al., 2006) . DRN DA-hM4Di and DRN DA-EGFP mice were habituated to experimenter handling for three days prior to intraperitoneal injection of saline or CNO (1 mg/kg) 3 hr into their dark (active) cycle, and EEG/EMG recordings took place for 2 hr afterward ( Figure 5C ). Compared to saline, CNO injection led to a marked reduction in wakefulness (Figures 5D and 5E) . At the group level, DRN DA inhibition decreased the time spent in wakefulness and increased NREM sleep time ( Figure 5F ). Specifically, CNO injection into the DRN DA-hM4Di mice increased NREM sleep duration ( Figure 5G ) but had no effect on the number of episodes of each state (Figure 5H ). Importantly, saline or CNO injection into control mice did not affect sleep-wake proportions (Figures 5F-5H). A change was also evident in cortical EEG ( Figure 5I ); contrary to optogenetic activation, chemogenetic inhibition was associated with increased delta (0.5-4 Hz) power ( Figure 5J ) and decreased high-frequency (40-100 Hz) activity ( Figure 5K ) relative to vehicle injection. To test whether CNO-induced sleep-wake states have normal EEG architecture, we verified that the EEG spectrum in each state after CNO injection was not distinguishable from those after saline injection ( Figures S5J-S5L ). Thus, our findings indicate that DRN DA neuronal activity is required for supporting wakefulness in normal physiological conditions. Figure 6A ). We introduced female mouse and predator odor TMT to the subject's home cage during the dark cycle while monitoring behavioral states. These two stimuli, which were shown to induce robust DRN DA activity (Figures 1C, 1D, and S2E) , hold ethological relevance and are of opposite valence. CNO injection into the DRN DA-hM4Di mice reduced the time spent awake and promoted NREM sleep in both assays, contrary to other conditions where mice remained awake ( Figures 6B and 6C ). More broadly, DRN DA inhibition during these assays caused a shift in cortical EEG spectra; CNO treatment of DRN DA-hM4Di mice led to an increase in delta (0.5-4 Hz) power and decreases in high-theta (8-12 Hz) and high-frequency (40-100 Hz) power relative to saline condition, which was absent in control mice ( Figures 6D-6G ). We further asked if the unexpected presentation of arousing or alerting stimuli (e.g., loud noises) during sleep could induce immediate wake transitions with DRN DA firing. DRN DA-GCaMP6s mice were exposed to randomized auditory stimuli (65 dB, 2-5 kHz, 2 Hz pulse frequency, 250 ms width, 10 s duration) throughout their light phase while recording GCaMP6s fluorescence and EEG/EMG signals ( Figure S6A ). We observed timelocked DRN DA activity upon tone onset, which was most prominent when subjects immediately (within 10 s) switched from sleep to wake ( Figures S6B and S6C ). There was no detectable difference in DRN DA activity increase between NREMand REM-to-wake transitions ( Figures S6D and S6E) . To test for a causal contribution of DRN DA activity to cued arousal, we repeated the above experiment on mice expressing archaerhodopsin-3 (Arch; Mattis et al., 2011) , which allows for time-locked reversible inhibition ( Figures S6F and S6G) . When DRN DA neurons were exposed to a continuous 20 s light pulse (532 nm, 10 mW) centered on tone delivery (70 dB), the probability of cued waking from NREM ( Figures S6H-S6K ), but not from REM sleep (Figures S6L-S6O) , significantly decreased. DRN DA inhibition did not completely block NREM-to-wake transitions, which suggests that multiple pathways likely work together to sustain full arousal, including, but not limited to, noradrenergic or cholinergic neurons (Aston- Jones and Bloom, 1981; Xu et al., 2015) . In sum, these data indicate that DRN DA activity is required for maintaining salience-induced wakefulness and for triggering cued waking from sleep.
DISCUSSION
Using simultaneous calcium imaging and polysomnography in conjunction with optogenetic and chemogenetic manipulations, we demonstrated that DRN DA neurons respond to external salient events of positive and negative valence, show correlative fluctuations at the population level across distinct sleep-wake states, and promote wakefulness. Furthermore, DRN DA activity is necessary to maintain normal levels of wakefulness and support arousal in response to the perception of salient stimuli. These findings support a role for wake-promoting DRN DA neurons that parallels the arousal-promoting function of isolated DA cells in invertebrates (Pimentel et al., 2016) , as well as a more expansive role for DRN DA signaling beyond promoting social interaction via negative reinforcement (Matthews et al., 2016) or mediating anti-nociceptive effects (Li et al., 2016) .
Our photometry data demonstrate not only that social interaction robustly enhances DRN DA spiking (female interaction, male intruder; Figures 1 and S2 ), akin to previous findings (juvenile interaction; Matthews et al., 2016) , but also that these neurons respond to the perception of highly salient, non-social stimuli (Figures 1 and S2 ). DRN DA activation by a wide variety of rewarding and aversive stimuli, both social and non-social, occurred irrespective of the subject's social history, as the stimulus-evoked change in DRN DA fluorescence was not influenced by chronic separation from cage-mates ( Figures S2J-S2M ). Given the subtleties in how various forms of social deprivation (e.g., maternal separation, acute or chronic social isolation) can differentially alter physiology and behavior (George et al., 2010; Whitaker et al., 2013) , the extent to which a subject's social environment and rank causes plasticity in DRN DA neurons will require further investigation. Based on the documented heterogeneity of ventral midbrain DA groups (Bromberg-Martin et al., 2010; Morales and Margolis, 2017) (D) Probability of being awake was dramatically increased upon onset of the phasic stimulation, with concurrent reduction of both NREM and REM state probability in DRN DA-ChR2 mice.
(E) Same as (D), but no change was observed in DRN DA-EGFP mice.
(F) The increase in wake probability in DRN DA-ChR2 mice compared with DRN DA-EGFP mice was significant, as were the decreases in NREM and REM sleep probability (n = 8 per group; unpaired t test, ****p < 0.0001).
(G) There was no difference in the latency to wake onset even after 4 hr of sleep deprivation in both groups (n = 4 per group; paired t test, p > 0.2). Regardless of sleep deprivation, latency to wake after stimulation was significantly shorter in DRN DA-ChR2 mice compared to controls (unpaired t test, *p < 0.05, **p < 0.01).
(H) Power spectral density of frontal EEG shows reduced power in low-frequency range and increased power in high-frequency range during light ON (blue) compared to light OFF (gray) conditions in DRN DA-ChR2 mice.
(I) Same as (H), but power spectral density showed no difference across light ON (orange) and OFF (gray) conditions in DRN DA-EGFP mice.
(J) Left: time-varying spectral analysis showed that the amplitude of delta (0.5-4 Hz) rhythms was decreased upon phasic stimulation. Right: delta amplitude during the light ON epoch was significantly decreased compared to baseline OFF epochs (n = 8 per group; two-way ANOVA revealed group 3 epoch interaction, F 2,26 = 17.06, p < 0.0001; Bonferroni post hoc analysis, ****p < 0.0001).
(K) Left: the amplitude of high-frequency (40-100 Hz) rhythms was increased upon phasic stimulation. Right: high-frequency amplitude was significantly increased during the light ON epoch compared to the OFF epochs (n = 8 per group; two-way ANOVA revealed group 3 epoch interaction, F 2,26 = 5.096, p < 0.05; Bonferroni post hoc analysis, **p < 0.01).
(L) 1 hr of phasic DRN DA stimulation significantly increased the time spent in wakefulness during the light ON hour compared to the light OFF hours (n = 6 per group; two-way ANOVA revealed group 3 epoch interaction, F 2,20 = 15.99, p < 0.0001; Bonferroni post hoc analysis, ***p < 0.001).
(M) 1 hr of phasic stimulation significantly increased the duration of wake episodes (n = 6 per group; two-way ANOVA revealed group 3 epoch interaction, F 2,20 = 12.16, p < 0.001; Bonferroni post hoc analysis, ***p < 0.001).
(N) Power spectral density revealed decrease in low-frequency power and increase in high-frequency power in DRN DA-ChR2 mice during light ON compared to the light OFF hours, but no changes were observed in DRN DA-EGFP mice.
(O) Stimulation-induced delta (0.5-4 Hz) power reduction was significantly larger in DRN DA-ChR2 mice (n = 6 per group; unpaired t test, *p < 0.05).
(P) Stimulation-induced high-frequency (40-100 Hz) power increase was significantly larger in DRN DA-ChR2 mice (n = 6 per group; unpaired t test, **p < 0.01).
Data represent mean ± SEM. (legend continued on next page) Matthews et al. (2016) further demonstrated that DRN DA neurons signal aversion, a trend that was also corroborated, albeit weakly, by our data ( Figure S4M ). This is in stark contrast with wake-promoting VTA DA neurons, whose activity supports robust place preference and operant responding (Tsai et al., 2009; Witten et al., 2011) . That neural circuits may be involved in two (D) Power spectral density analysis during female mouse interaction revealed CNO-induced increase in low-frequency power and decrease in high-theta (8-12 Hz) and high-frequency power in DRN DA-hM4Di mice with respect to the saline condition but no change in control mice.
(E) CNO-induced increase in delta (0.5-4 Hz) power and decrease in high-theta (8-12 Hz) and high-frequency (40-100 Hz) power were significantly larger in DRN DA-hM4Di mice than in controls (n = 4 per group; unpaired t test, **p < 0.01, ***p < 0.001).
(F) Same as (D), but for the TMT condition. A similar trend was observed as (D).
(G) CNO-induced increase in delta (0.5-4 Hz) power and decrease in high-theta (8-12 Hz) and high-frequency (40-100 Hz) power were significantly larger in DRN DA-hM4Di mice than in controls (n = 4 per group; unpaired t test, *p < 0.05, **p < 0.01).
Data represent mean ± SEM. seemingly unrelated roles, valence encoding and sleep-wake regulation, is not unique to midbrain DA groups; wake-promoting LC NA neurons and CRH inputs also convey negative valence (McCall et al., 2015) . Considering the involvement of hypocretin and VTA DA systems in reward behavior (Españ a, 2012; Wise, 2004) , there may be dichotomous wake-promoting pathways signaling positive or negative valence upon their activation. That DRN DA neurons can simultaneously send arousal and anti-nociceptive signals (Li et al., 2016) can be understood by considering DRN DA connectivity with the bed nucleus of stria terminalis (BNST; Figure S4Q ), which is a critical regulator of pain perception (Minami and Ide, 2015) . Compared to ventral midbrain DA counterparts (Schultz, 1997; Ungless et al., 2004; Matsumoto and Hikosaka, 2009; Cohen et al., 2012; Lerner et al., 2015; Kim et al., 2016) , the natural dynamics of DRN DA neurons are much less characterized. Due to their relative low number and shared projection targets, DRN DA neurons have been assumed to be functionally similar to VTA DA neurons and hence termed the dorso-caudal extension of the VTA (A10) or A10 dc group (Hokfelt et al., 1984) . Several pieces of evidence argue against their treatment as a mere extension of the VTA. Unlike the well-studied dorsal or lateral VTA DA neurons, which fire bursts in response to rewarding or reward-predicting stimuli and are inhibited by punishment (Schultz, 1997; Ungless et al., 2004; Cohen et al., 2012; Kim et al., 2016) , or the ventromedial VTA DA neurons, which are selectively excited by aversive stimuli (Brischoux et al., 2009) , DRN DA neurons appear to be activated by any alerting or salient stimulus, regardless of valence (Figures 1 and S2) . Also, they appear to be minimally affected by physically salient but motivationally neutral cues, such as novel or familiar objects (Figure 1 ). Since both rewarding and aversive stimuli elicit arousal and motivated responding, the VTA DA system may address this challenge of dual positive (Schultz, 1997) and negative (Brischoux et al., 2009; Matsumoto and Hikosaka, 2009; Zweifel et al., 2011) valence coding in part through segregating to functionally and electrophysiologically distinct subgroups split across anatomical gradients (Brischoux et al., 2009; Bromberg-Martin et al., 2010) or projection targets (Lammel et al., 2011 those projecting to the nucleus accumbens, supports both appetitive conditioning and positive reinforcement behavior (Wise, 2004; Witten et al., 2011; Steinberg et al., 2014) , whereas stimulation of DRN DA neurons produces neutral or mild aversion ( Figure S4M ; Matthews et al., 2016) . These observations may be indicative of differences in downstream connectivity between these neuronal populations. Although DRN DA and VTA DA neurons share overlap in some of their downstream targets (e.g., the prefrontal cortex and the basolateral amygdala), DA neurons projecting to cortical and striatal regions predominantly arise from the VTA (Bjö rklund and Dunnett, 2007). DRN DA terminals, however, are biased toward the extended amygdala, such as the BNST and central nucleus of the amygdala (CeA) (Figures  S4P-S4S ; Hasue and Shammah-Lagnado, 2002) . Thus, as a major source of excitatory DA drive to the BNST and CeA (Matthews et al., 2016) , two regions known to bi-directionally affect motivated behavior and regulate complex emotional states (Jennings et al., 2013) , DRN DA neurons are uniquely positioned to provide excitatory signals about environmental salience and internal arousal state to downstream nuclei, which can in turn initiate appropriate behavior, including triggering vigilance or patterning sleep-wake states.
Although DA has been implicated in sleep-wake regulation by pharmacological (Lin et al., 1992) , genetic (Wisor et al., 2001) , and clinical (Lima, 2013) at the interface between internal (e.g., wake/sleep drive) and external (e.g., salient stimuli) influences in regulating sleepwake states. While this evolutionarily conserved trait is advantageous for organism survival, its dysfunction may have negative implications in humans, in which sleep disorders triggered by the malfunctioning of arousal-promoting circuits represent a highly morbid societal burden (Sanford et al., 2015) . DRN DA neurons are not well studied in humans, but it has been shown that they degenerate in patients with multiple systems atrophy and Lewy body dementia, which commonly cause excessive daytime sleepiness (Benarroch et al., 2009) . Going forward, therapeutic strategies targeting DRN DA activity may have utility in the treatment of primary sleep-wake disorders and sleep/arousal disturbances secondary to myriad neuropsychiatric diseases (Sateia et al., 2000) , including major depressive disorder, bipolar affective disorder, and schizophrenia.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Surgeries for viral delivery, optical fiber and EEG/EMG implantation General surgical procedures and viral delivery Mice were anesthetized with isoflurane gas/carbogen mixture (5% for induction and 1.5%-2% for maintenance during surgery) and placed to a stereotaxic frame (David Kopf Instruments, CA, USA). After shaving their hair and sterilizing the skin with chlorohexidine, a midline incision was made with a sterile scalpel. The skull surface was wiped and cleaned with autoclaved cotton swabs. Bregma and lambda were identified and leveled to be on the same z axis. Small craniotomy holes were made for 20 degree angled injection of viruses and optical fiber implantation over the dorsal raphe nucleus (DRN, antero-posterior (AP) axis: À4.65 mm, medio-lateral (ML) axis: ± 1.2 mm, relative to Bregma). Adeno-associated viral vectors (AAV, see below for details) were injected into the DRN (AP À4.6 mm, ML ± 1.2 mm, dorso-ventral (DV) À2.95 mm, at a 20 degree angle relative to vertical axis from the left and right sides). Viral injection was performed using a blunt 35-gauge microinjection needle within a 10 uL microsyringe (NanoFil, World Precision Instruments, FL, USA), which was controlled by a microsyringe pump (UMP3, World Precision Instruments) connected to a controller (Micro4, World Precision Instruments). 0.3-0.5 uL of AAV was infused per site at a rate of 50 nL per min. Following injection, the needle/syringe was held in the same location for an additional 10 min to allow further diffusion. To prevent potential backflow, the needle/syringe was slowly withdrawn over approximately 10 min.
EEG and EMG implantation
To implant the EEG/EMG apparatus, three additional craniotomy holes were made in frontal (for first EEG channel; AP +2.0 mm, ML +0.7 mm), central (for second EEG channel; AP À1.3 mm, ML +1.3 mm) and lateral parietal (for reference and ground; AP À3.5 mm, ML À2.5 mm) regions with a drill bit (#73, 105-0240.340, Kyocera, Kyoto, Japan). 0.10'' electrodes with wire leads (8403, Pinnacle Technology Inc., KS, USA) were screwed into the craniotomy holes. With the leads from the screw electrodes held away from the surface of the skull to prevent accidental glue application, a thin layer of adhesive cement (C&B Metabond, Parkell Inc., NY, USA) was applied on the skull surface to secure the screw electrodes. Another thin layer of dental cement (51458, Stoelting Co., IL, USA) was additionally applied until it covered screw heads. The EEG/EMG headmount (8201, Pinnacle Technology Inc.) was then placed on the dental cement layer and lead wires from screw electrodes were connected to the headmount. Silver epoxy (MG Chemicals, BC, Canada) was applied to ensure electrical conduction between the lead wires and headmount. An additional layer of dental cement was applied to secure the headmount to the animal's head. Finally, EMG leads from the headmount were inserted into the trapezius muscles and then the incision was closed. Optical fiber implantation (for fiber photometry and optogenetic experiments) Following virus infusion, an optical ferrule/fiber with cut length of 4 mm and diameter of 300 um (for optogenetics, NA 0.37, homemade) or 400 um (for fiber photometry, NA 0.48, Doric lenses, Quebec, QC, Canada) was firmly mounted to a stereotaxic holder (1766AP, David Kopf Instruments, CA, USA). An optical ferrule/fiber was then inserted to the DRN (AP À4.6 mm, ML ± 1.2 mm, DV À2.5$2.7 mm, at a 20 degree angle relative to vertical axis from either left or right side) through a craniotomy hole, and stopped 200 (for fiber photometry) or 500 um (for optogenetics) above the viral injection site. A thin layer of adhesive cement was applied on the skull surface to strongly hold the ferrule/fiber. After adhesive cement was completely dried, a thick layer of pink dental cement was applied to build a robust head cap. Viral constructs For fiber photometry experiments, 0.5 uL of AAV serotype 5 encoding GCaMP6f or GCaMP6s (Chen et al., 2013) under synapsin promoter and Cre-dependent FLEX switch (AAV5-Syn-FLEX-GCaMP6f or GCaMP6s, 1.0-1.5 X 10 13 genome copies/mL) was unilaterally injected. GCaMP6 viruses were packaged and purchased from the University of Pennsylvania Vector Core (Philadelphia, PA, USA). For optogenetic activation experiments, 0.3 uL of AAV serotype 5 encoding ChR2-eYFP under Ef1a promoter and doublefloxed inverse open reading frame (DIO) (AAV5-Ef1a-DIO-ChR2(h134R)-eYFP, 4.5 X 10 12 genome copies/mL) was bilaterally injected.
For chemogenetic experiments, 0.3 uL of AAV serotype 2 encoding hM4Di-mCherry under human synapsin promoter and DIO switch (AAV2-hSyn-DIO-hM4Di-mCherry, 4.0 -5.0 X 10 12 genome copies/mL) was bilaterally injected. For optogenetic inhibition experiments, 0.5 uL of AAV serotype 5 encoding eArch3.0-eYFP under Ef1a promoter and DIO frame (AAV5-Ef1a-DIO-eArch3.0-eYFP, 3.4 X 10 12 genome copies/mL) was bilaterally injected. For control animals, 0.5 uL of AAV5-hSyn-DIO-eGFP (4.7 X 10 12 genome copies/mL) was bilaterally injected. ChR2-eYFP, hM4Di-mCherry, eArch3.0-eYFP and eGFP viruses were packaged and purchased from the University of North Carolina Vector Core (Chapel Hill, NC, USA). hM4Di-mCherry vector was also purchased from Addgene (Cambridge, MA, USA).
Fiber photometry
Fiber photometry is a method of measuring population Ca 2+ sensitive fluorescence from genetically defined cell types in deep brain structures, such as TH-expressing neurons in the DRN, using a single optical fiber for both excitation and emission in freely moving mice (Gunaydin et al., 2014) . We based our photometry design from a previous literature (Lerner et al., 2015) with a few modifications. -independent with GCaMP6 and to mostly reflect bleaching and motion artifacts (Lerner et al., 2015; Kim et al., 2016) : thus, this signal serves as a control reference signal. 490 nm and 405 nm excitation lights were passed through GFP and violet cleanup excitation filters (FF02-472/30-25 and FF01-400/40-25, Semrock, NY, USA) respectively, and reflected off dichroic mirrors (DMLP425 and MD498, Thorlabs). Excitation light was coupled into a low auto-fluorescence 400 um patch cord (0.48 NA, 2 m cable length, Doric lenses) with a high NA coupler/collimator (F240FC-A, Thorlabs). Another end of the patch cord was connected to a ceramic optical ferrule/fiber (1.25 mm diameter ferrule, 400 um diameter fiber core) implanted into the brain region of interest in subjects. The LED powers for both excitation wavelengths were measured with a power meter (PM100D, Thorlabs) and set to be 50-80 uW at the end of the patch cord. GCaMP6 emission signals were collected through the patch cord and collimator and passed through a dichroic mirror (MD498, Thorlabs) and a GFP emission filter (MF525-39, Thorlabs) to reach a femtowatt photoreceiver (Model 2151, Newport Co., Irvine, CA, USA) using a focusing lens (62-561, Edmunds Optics, Barrington, NJ, USA). Photoreceiver signals were relayed into a RX8-2 processor through a BNC cable and were demodulated into two signals, corresponding to each LED excitation wavelength based on its modulation frequency. These outputs were digitized at a sampling rate of 382 Hz and low-pass filtered at 15 Hz. One digital input channel was additionally acquired to record any TTL pulses from an external source in order to synchronize transients with EEG/ EMG, video recording, and/or behavioral events. Custom-written software was used to control data acquisition and signal visualization.
Behavioral experiments
All behavioral experiments involving fiber photometry were performed at least 2 weeks after viral injection. Behavioral tests with optogenetics were performed at least 4 weeks after surgery to allow maximal transgene expression. Mice underwent the following assays during their dark phase (10AM-5PM) in their residence room, unless otherwise stated.
Resident-intruder assay
Mice with an implanted optical fiber were connected to a patch cord for recording of fiber photometry. After connection, mice were placed back into their home cages and habituated to the open cage setup for 10 min. After habituation, a juvenile male (3-4 weeks old), adult female (2-3 months old), or adult male (2-3 months old) mouse was introduced as an intruder into each home cage. Video recording was performed and synchronized with fiber photometry signals. After 5 min, the intruder mouse was removed from the home cage. The behavior of resident mice, such as investigation and attack (observed only toward adult males), was manually scored by an experimenter.
Novel object interaction assay
The novel object interaction test setup was almost identical to the resident-intruder assay, but a distinct novel object was placed into the center of the empty cages instead of an intruder mouse. To run the test, mice were connected to the photometry patch cord, and habituated to being tethered in the open empty cage environment. Then, a novel object was introduced, and the subject was allowed to freely explore the object for a 5 min test session. Behavior scoring was manually performed to identify interaction bouts, which consisted of the subject approaching, sniffing, and/or touching of the object with forelimbs. Familiar object interaction assay This assay was similar to the novel object interaction assay described above, except that the designated familiar object (similar size and characteristics as used for the novel objects) was placed into the subject's home cage 5 days prior to photometry recording sessions. Feeding assay Two days before the experiment, the palatable food treat (approximately 1 g of peanut butter chocolate pieces (Reese's peanut butter cups)) was presented to each mouse for consumption. After connecting the mouse to the patch cord, they were placed in a clean, empty cage. After 5 min of habituation, approximately 2 g of treats in a small weighing boat were introduced into one of the cage corners. All tested subjects approached and consumed the treat after variable delays. Leftover treats were removed after 10 min. Video recordings were manually scored to identify food consumption bouts. Air puff Mice were connected to a patch cord and placed in a clean empty cage without any bedding. Mice were allowed to explore and habituate for 5 min. Six brief (< 1 s) air puffs were applied to the tail using a compressed air duster with an inter-puff interval of 30-60 s. TTL pulses were sent to the fiber photometry digital input channel for time stamping when air puffs were applied. Unpredictable delivery of electric footshocks Mice were connected to a patch cord and placed inside an operant chamber (Lafayette Instruments, IN, USA). Mice were allowed to explore and habituate to the operant box for 10 min. Two mild footshocks (0.3 mA, 1 s) were delivered with intervals of about 30 s. TTL pulses were sent to the fiber photometry digital input channel for accurate time stamping.
Exposure to predator odor Mice were connected to a patch cord and moved to a clean empty cage. To habituate to this new environment, mice were allowed to explore for 5 min. After photometry recording started, a filter paper applied with 10 uL of 2,3,5-trimethyl-3-thiazoline (TMT, a component of fox urine, SRQ Bio, Inc, FL, USA) was introduced to the cage corner. Simultaneous photometry and video recordings were performed to identify the time point of odor investigation. Restraint/Immobilization A test subject was connected to a patch cord and placed to a clean empty cage. A 5 min habituation session was conducted in which the subject was allowed to freely explore the cage. At the start of fiber photometry recording, 3 min of baseline data were obtained. Then, taking care not to cause significant pain to the subject, a trained experimenter restrained the subject for one minute by placing gentle pressure on the mouse body with the left hand and immobilizing the tail with the right hand. All subjects engaged in active struggling and escape behaviors. Recordings were terminated after 3 min of recovery. Tail suspension test Mice were connected to a patch cord, and the tail was placed between strips of common lab tape, which was affixed to a horizontal bar suspended about 50 cm from the ground. We additionally put a lightweight ($1 g) plastic cylinder around the tail to prevent the mouse from climbing onto the tail. Synchronized fiber photometry and video recordings were performed for 5 min, and video was manually and blindly scored to pinpoint ''mobility'' bouts during which the animals struggled by moving their bodies.
Open field test
Mice were connected to a patch cord, transferred to the open field box (50 cm x 50 cm x 25 cm), and habituated to this setup for 10-15 min prior to the start of 15 min test sessions. A video camera positioned above the behavioral arena and connected to EthoVision XT 9 software (Noldus Information Technology, Wageningen, Netherlands) allowed tracking of subject position and velocity throughout the test session. Fiber photometry and video recordings were synchronized via TTL pulses generated by the Noldus USB-IO box. Fiber photometry experiments took place during the subjects' dark phase (10AM-5PM). For optogenetic experiments, open field tests were performed during both the dark phase (9AM-1PM) and light phase (6PM-10PM) to examine whether locomotion varied across the circadian cycle. The order of open field test sessions during dark and light phases was counterbalanced. Real-time place preference/aversion assay A subject was connected to a patch cord and transferred to the open field box (50 cm x 25 cm x 25 cm), which was divided into left and right compartments. The subject was given free access to explore the two compartments for 30 min. However, upon entering the ''paired chamber,'' the subject received phasic bursts of optogenetic stimulation (30 Hz, 10 pulses, 10 ms pulse width, every 5 s). The side paired with optogenetic stimulation was counter-balanced. EthoVision XT 9 software (Noldus) was used to track the movement and location of mice. As a dependent variable, time spent in the paired compartment was quantified.
EEG/EMG data acquisition, processing, and sleep-wake state classification After EEG/EMG implantation surgery, animals were single-housed for four weeks in a regular mouse cage for recovery and transgene expression. Mice were then transferred to a transparent cylindrical cage (12 0 ' diameter and 12'' height) and connected to a customized pre-amplifier (10x gain, 0.5 Hz high-pass filter, 10 Hz high-pass filter for EMG; Pinnacle Technology Inc., Lawrence, KS, USA) and a commutator (8204, Pinnacle Technology Inc.) for freely moving recordings. They were habituated for at least seven days to the recording setup before beginning any experiments. On the 7 th day, four animals were randomly selected per group (depending on the viral transgene they expressed) and 24 hr baseline recordings were performed to test whether viral transgene expression or other experimental artifacts altered the sleep-wake architecture of subjects. Food and water were available ad libitum. EEG/EMG signals were digitized through the OmniPlex System (Plexon, TX, USA) with a sampling rate of 1,000 Hz in most experiments, or through Pinnacle Sirenia Acquisition (Pinnacle Technology Inc, KS, USA) with a sampling rate of 400 Hz (for 24 hr baseline recordings and chemogenetic experiments in presence of salient stimuli). Mice with lost EEG and EMG signals were excluded from the experiment -very occasionally, some mice showed a low signal-to-noise ratio or unintelligible EEG/EMG traces. Data acquired in Plexon's or Pinnacle's proprietary file format (.pl2 or .pvfs) were converted to European data format (.edf) with MATLAB (MathWorks, MA, USA) using the EEGLAB plug-in (Schwartz Center for Computational Neuroscience, La Jolla, CA, USA). Polysomnographic EEG/EMG recordings were loaded, and behavioral states were scored using sleep analysis software (SleepSign for Animal, Kissei Comtec Co., Nagano, Japan).
Sleep-wake state classification is manually performed based on visual and spectral signatures of EEG and EMG signals. States were assigned across consecutive non-overlapping 5 s windows. We defined wakefulness as desynchronized, low-amplitude, and high-frequency EEG rhythms with elevated EMG activity. We defined NREM sleep as synchronized, high-amplitude, and lowfrequency (< 4 Hz) EEG activity with lower tonic EMG tone. We defined REM sleep as containing prominent theta (6-10 Hz) oscillations on EEG and minimal EMG activity. All sleep-wake state scorings were performed by an experimenter (J.R.C.), who was blind to expressed transgene and experimental conditions.
Optogenetic and chemogenetic modulation of behavioral states and locomotion For optogenetic experiments, one side of a patch cord (1.25 mm ceramic ferrule, 300 um diameter, Doric lenses) was connected to the implanted optical ferrule/fiber with another side (FC/PC connector) connected to a swivel commutator (fiber-optic rotary joints, FRJ_1x1_FC-FC, Doric lenses) to allow free movement. Another patch cord was connected from the commutator to a 473 nm laser (MLL-FN-473nm/150mW, Changchun New Industries Optoelectronics Technology, Changchun, China). The intensity of the laser beam was measured with an optical power meter (PM100D, Thorlabs) and set to be 10 mW at the tip. Laser output was controlled by a TTL pulse generator (OTPG4, Doric lenses) via a BNC cable. For phasic stimulation, ten 30-Hz, 10-ms pulses were applied every 5 s. For tonic stimulation, continuous 2-Hz, 10-ms pulses were used. These phasic and tonic parameters were chosen to have the same number of pulses for a given duration but with distinct temporal pattern. Both phasic and tonic patterns of stimulation were applied for 2 min with intervals of 20-25 min. Animals used for optogenetic experiments were always connected to the preamplifier and Plexon system to continuously acquire EEG and EMG signals for sleep-wake state classification. TTL signals for controlling laser output were split and input into the Plexon acquisition system through an analog input for accurate time stamping of triggered stimulation. All optogenetic experiments with EEG/EMG monitoring were carried out during the light phase (6 PM-6 AM).
To test whether the wake-promoting effect of DRN DA activation was mediated by direct action of DA, DRN DA-ChR2 and DRN DA-eGFP mice that were habituated to the recording setup were systemically administered dopamine receptor antagonists SCH-23390 (a selective D1 antagonist, 1 mg/kg) and eticlopride (a selective D2 antagonist, 1 mg/kg) 45 min before the onset of the light phase. The concentration of these dopamine antagonists was selected based on a previous literature . For controls, we injected sterile saline at the same circadian time. EEG/EMG recording and phasic optogenetic stimulation started at the light phase onset and lasted for 2 hr.
To study whether the wake-promoting effect of optogenetic DRN DA stimulation is influenced by homeostatic sleep pressure, DRN DA-ChR2 or DRN DA-eGFP mice were sleep deprived for 0 or 4 hr by gentle handling . The order of experiments (0 or 4 hr deprivation) was counter-balanced across animals. For sleep deprivation, mice were continuously monitored by an experimenter (with EEG and EMG recordings turned on). Mice were softly touched by a brush whenever they become motionless and/or exhibited reduced EMG tone or absent EMG bursts. After the sleep deprivation procedure, two phasic bursts (30 Hz, 15 pulses, 10 ms width, 5 s interval) were applied about 5$10 min after they entered into NREM sleep, and the latency to wake transitions was measured.
To study the causal effect of increased DRN DA activity on locomotion, we performed the open field test with DRN DA-ChR2 and DRN DA-eGFP mice. Procedures and experimental equipment were similar those described above for open field testing during fiber photometry, with video monitoring and subject position and velocity tracking recorded throughout all sessions. Mice were first habituated in the open field for 20 min. After acquiring 20 min of baseline activity (not including habituation), laser stimulation (phasic or tonic patterns) was delivered for 5 min. After stimulation, five additional minutes were recorded. Throughout testing, distance traveled during 5 min epochs (before, during, and after stimulation) were analyzed.
For chemogenetic experiments, animals with hM4Di-mCherry or eGFP injection were connected to the data acquisition system for EEG and EMG signals. Animals were habituated to experimenter handling for 3-4 days before any experiments commenced. Saline or clozapine-N-oxide (CNO, selective ligand for hM4Di, 1 mg/kg dissolved in saline; Enzo Life Sciences Inc., Exeter, UK) was intraperitoneally injected immediately prior to the start of testing at 9 AM (3 hr after dark phase onset). Recordings were carried out for 2 hr following injection.
To test whether DRN DA neuronal activity is required for wake maintenance after exposure to salient environmental stimuli, DRN DA-hM4Di or DRN DA-eGFP mice (which were already habituated to experimenter's handling) were first injected with saline or CNO (1 mg/kg) 45 min before testing. Then, a female mouse (contained in an inverted wire cup, thus not directly accessible for mounting) or a filter paper with predator odor TMT was introduced into the recording cage. We chose these two stimuli because they are of opposite valence (positive versus negative) and were shown effective in inducing robust DRN DA neuronal activity (See Figures 1 and S2 ). EEG/EMG recording began immediately after introduction of the salient stimulus and lasted for 1 hr.
Auditory cue arousal test
To examine whether DRN DA firing mediates cue-induced arousal from sleep, we performed simultaneous recording of fiber photometry and EEG/EMG signals on DRN DA-GCaMP6s mice. On each experimental day, recordings began at the light phase onset (6PM). Auditory tonal stimuli (65 dB; 2, 3, or 5 kHz frequency; 2-Hz pulse; 250-ms pulse width, 10 s duration) were randomly applied during the first half of the light phase (for 6 hr) with a minimum inter-trial interval of 15 min from a speaker located adjacent to the testing cages. In order to limit habituation to specific tonal frequencies, three different tones were administered in random order with a 33.3% probability for each frequency. The speaker was placed 30 cm away from the cage, and the auditory tone intensity inside the cylindrical cage was calibrated with a sound meter (Digital Sound Level Meter, Foneso, Shenzhen, China) before the beginning of each session with mice temporarily removed from the room. TTL pulses time-locked to the auditory cues were generated and inputted into the Plexon data acquisition system for accurate time stamping.
Sleep-wake states were classified as described above by an experimenter (J.R.C.) who was blind to the experimental conditions. Depending on the behavioral consequence of auditory cues, each trial was classified as 1) sleep-to-wake transitions (further divided from NREM or from REM sleep), 2) sleep-to-sleep (when auditory cue failed to induce wakefulness), and 3) wake-to-wake (auditory stimuli that were administered during wakefulness) cases. In order for a trial to be scored as a sleep-to-wake transition, animals had to show at least 3 s of wake EEG and EMG signs (EEG: desynchronized from delta or theta rhythm, EMG: sudden phasic elevation of muscle activity) within 10 s of the auditory cue onset. If these criteria were not met, the trial was categorized as sleep-to-sleep.
To test for the necessity of DRN DA firing in auditory cue-induced arousal from sleep, we inhibited DRN DA neurons in a time-locked manner with the inhibitory proton pump eArch3.0 (Arch). The experimental setup was identical to the procedure described above, except we used a slightly higher intensity tone (70 dB) to avoid possible floor effects, and 20 s of 532 nm green laser (10 mW at the tip) was continuously applied surrounding the tone presentation (starting 5 s before the tone, terminating 5 s after the end of the tone) to the DRN DA-Arch or DRN DA-eGFP mice. Only data epochs when auditory cues were turned on during NREM or REM sleep were considered and we manually reviewed whether auditory tones caused wake transitions (see above for specific criteria). If cues successfully woke up the animal, they were categorized as 'NREM-to-Wake' or 'REM-to-Wake' trials. If tones did not lead to immediate wake transitions, they were categorized as 'NREM-to-NREM' or 'REM-to-REM' trials. To confirm that sleep-related oscillations (delta for NREM and theta for REM) were not perturbed in 'NREM-to-NREM' and 'REM-to-REM' trials, we calculated the delta and theta amplitude for NREM and REM, respectively, and determine whether there were any changes across the tone onset (see .
Data analysis
Fiber photometry data processing and analysis Acquired data files were loaded and processed with custom-written codes in MATLAB. Pre-processing was performed as previously described (Lerner et al., 2015) . Fiber photometry traces from 490 and 405 nm excitation wavelengths were first low-pass filtered at 2 Hz using a 4 th order Butterworth filter with zero-phase distortion. To calculate DF/F, a linear fit was applied to 405-nm signal and aligned to the 490-nm signal. The fitted 405-nm signal was subtracted from the 490-nm signal and then divided by the fitted 405-nm signal again to yield the DF/F time-series. To visualize peri-event photometry traces, DF/F data epochs were extracted around immediately before and after relevant behavioral events (e.g., event onsets identified by either video scoring or TTL pulses) and averaged. For statistical comparison between baseline and behavior, areas under the curve (AUC) per second values were calculated for given conditions. Similarly, to visualize Ca 2+ fluorescence change across state transitions, the temporal location of state transitions were identified, and 120 s of photometry traces around the transition time points were extracted and averaged. AUC was also calculated to compare DRN DA population activity before and after transitions. We performed analyses for NREM-to-wake, REM-to-wake, wake-to-NREM, and NREM-to-REM transitions. We excluded other possible combinations as rodents rarely transit directly from REM to NREM, and none of the tested mice showed wake-to-REM transitions, which is a common feature of narcolepsy. We termed periods of less than 15 s of wakefulness after REM state as ''short arousal'' and we separately plotted these transitions as ''REM-to-short arousal-to-NREM'' (See Figure S3L) .
To detect Ca 2+ peak events from photometry traces and quantify them across sleep-wake states, we first normalized the trace using z-score and then high-pass filtered at 0.01 Hz using 2 nd order butterworth filter with zero-phase distortion to eliminate possible low-frequency fluctuations across states. Then we detected prominent Ca 2+ peak events with an amplitude threshold, which was defined as the 75 th percentile of the entire photometry data amplitude distribution. This percentile threshold was heuristically chosen because the photometry amplitude distribution is positively skewed and does not follow Gaussian distribution, which makes it more sensitive to the presence of outliers (such as during Ca 2+ peak events). For quantification of these detected events, we calculated 1) peak amplitude, 2) duration (from detection onset to offset), 3) frequency or number of events in a 5 s window, and 4) summed AUC values of detected events in a 5 s window. In order to account for inter-subject variability in amplitude during investigations into the temporal dynamics of DRN DA activity during each behavioral state from onset to offset, we first converted the fluorescence traces into z-scores (calculated from the entire traces). Next, photometry traces from each state including 10% of the trace before and after were cropped and down-sampled to 120 points in order to normalize the timescale. This allowed us to project variable length photometry traces containing z-score normalized fluorescence changes onto the normalized time of À0.1 to 1.1, where 0 notes the onset and 1 notes the offset of a wake or sleep episode. To examine any correlation between DRN DA activity and locomotion, we obtained the synchronized recordings of fiber photometry and video tracking. To test if increased DRN DA activity is associated with any change in locomotion, we detected prominent Ca 2+ peak events as previously described above, extracted 10 s of velocity traces around peak event onsets, and then averaged. Conversely, to test if initiation of locomotion is associated increased DRN DA activity, we detected locomotion onset similarly as the Ca 2+ peak events (but with 65 th percentile as an amplitude threshold), extracted 10 s of photometry traces around locomotion onsets, and then averaged.
EEG spectrogram
To visualize spectral and temporal profiles of EEG activity across distinct behavioral states, we decomposed EEG into time-frequency plan using Morlet wavelet. EEG data epoch of interest was convolved with a complex Morlet wavelet, wðt; f 0 Þ, having a Gaussian shape both in the time ðs t Þ and frequency ðs f Þ domain around its central frequency, A wavelet family was characterized by a constant ðf 0 =s f Þ ratio of 6 from 1 to 20 Hz in 1 Hz steps. The time-varying energy of the signal, Eðt; f 0 Þ, is defined as the squared norm of the convolution product of a complex wavelet wðt; f 0 Þ, with the signal s(t): Eðt; f 0 Þ = jwðt; f 0 Þ3sðtÞj 2 .
Time-varying energy is then smoothed by a moving average filter with span of 2 s for each frequency step to enhance visualization. Calculation of EEG frequency band To extract time-varying amplitude of a certain EEG frequency band (e.g., 0.5-4 Hz for delta, 5-10 Hz for theta, and 40-100 Hz for highfrequency -notch filter was applied from 58 to 62 Hz before calculating high-frequency activity amplitude to avoid any contribution from 60 Hz line noise), the signal of interest was first band-pass filtered using a 2nd order Butterworth filter. A zero-phase shift filter was used to prevent any phase distortion. Instantaneous amplitude was obtained by taking the absolute value of the Hilbert transform of the band-passed signal. EEG frequency band amplitude signals were smoothed by a moving average filter (with 10 s window for Figures 4 and S4 and with 2 s window for Figures 6 and S6) and then normalized using z-score with respect to the baseline. EEG data epochs containing high-amplitude artifacts were excluded from analysis. Power spectral density Power spectral density was estimated for EEG data using a Welch's method. We used a 5 s window size and 50% overlap to estimate power from 0.5 to 100 Hz (except from 58 to 62 Hz). For 1 hr chronic optogenetic stimulation, spectral power changes during optogenetic stimulation with respect to the baseline (1 hr before the stimulation) were obtained for both DRN DA-ChR2 and DRN DA-eGFP mice. For chemogenetic experiments, spectral power changes of CNO conditions from saline conditions were calculated at each frequency step. EEG data epochs with high-amplitude artifacts were excluded from analysis. Efficiency and specificity of GCaMP6f+ expression Efficiency was defined as ''the number of GCaMP6f+ and TH+ neurons out of the total number of TH+ neurons.'' Specificity was defined as ''the number of GCaMP6f+ and TH+ neurons out of the total number of GCaMP6f+ neurons.''
Ex vivo electrophysiology TH-cre mice expressing ChR2-eYFP or hM4Di-mCherry were euthanized with carbon dioxide and transcardially perfused with icecold sucrose-based cutting solution saturated with 95% O 2 /5% CO 2 (carbogen) that contained (mM) 85 NaCl, 75 sucrose, 2.5 KCl, 1.25 NaH 2 PO 4 , 4.0 MgCl 2 , 0.5 CaCl 2 , 24 NaHCO 3 and 25 glucose. The brain was removed and 250-mm coronal slices that contained the DRN were prepared in oxygenated cutting solution using a vibratome (VT-1200, Leica Biosystems, IL, USA). Slices were recovered at 32 C for one hour prior to recording in carbogenated ACSF containing (mM): 125 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 1.2 MgCl 2 , 2.4 CaCl 2 , 26 NaHCO 3 , and 11 glucose. Slices were transferred to the recording chamber and perfused (1.5 -2.0 mL/min) with carbogen-saturated ACSF at 32 ± 0.5 C. Whole-cell patch clamp recordings of fluorescently tagged (TH+) DRN neurons were obtained using a MultiClamp 700B amplifier (Molecular Devices, CA, USA) and a Digidata 1440 analog-to-digital converter (Molecular Devices). Data were sampled at 10 kHz and filtered at 2 kHz with Clampex 10.4 (Molecular Devices). Patch electrodes had resistance of 4 -6 MU and were filled with a potassium gluconate intrapipette solution (mM): 135 K gluconate, 5 KCl, 5 EGTA, 0.5 CaCl 2 , 10 HEPES, 2 Mg-ATP, and 0.1 GTP. Electrophysiological data were analyzed with Clampfit 10.4 (Molecular Devices). For Figure S4A , light-evoked currents (voltage clamp) and action potentials (current clamp) were evoked by ten of 30 Hz (10 ms pulse width) blue (420-455 nm) light delivered by an LED light source (Lumencor, OR, USA) in neurons held at À70mV. Once we patched hM4Di-mCherry+ or eGFP+ DRN DA cells ( Figures S5A-S5E ), neuronal firing was evoked by depolarizing the membrane potential to À45 mV in current clamp mode. After collecting baseline for $2 min, 1 mM of CNO was applied to the bath for neuronal silencing. After 3-4 min, CNO was washed out.
Histology Perfusion Mice were euthanized with CO 2 and transcardially perfused with 20 mL of ice-cold 1x PBS with heparin (10 U/mL) and then with 30 mL of ice-cold 4% PFA in 1x PBS. Mouse brains were carefully removed from the skull and post-fixed in 4% PFA at 4 C overnight. The 4% PFA solution was switched to 1x PBS in the morning. Brains were sectioned into 50 mm coronal slices with a vibratome (VT1200, Leica Biosystems, IL, USA). Slices were stored in 1x PBS at 4 C until immunohistochemical processing. Immunohistochemistry Brain sections were incubated in a 1x PBS solution containing 0.1% Triton X-100 and 10% normal donkey serum (NDS; Jackson ImmunoResearch, PA, USA) with primary antibodies (see below for details) at 4 C overnight. Afterward, sections were thoroughly washed four times (15 min each) in 1x PBS and temporarily stored at 4 C. Sections were then transferred into a secondary antibody cocktail, which included 1xPBS with 0.1% Triton X-100, 10% NDS with secondary antibodies (see below for details), and stored at 4 C overnight. The next morning, sections were again washed by 1x PBS solution four times (15 min each), mounted on glass microscope slides (Adhesion Superfrost Plus Glass Slides, #5075-Plus, Brain Research Laboratories, MA, USA), dried, and coverslipped with a DAPI-containing mounting media (Fluoromount G with DAPI, 00-4959-52, eBioscience, CA, USA). Antibodies For primary antibodies, anti-chicken TH (1:500; TYH, Aves Labs, OR, USA), anti-rabbit TH (1:500; sc-14007, Santa Cruz Biotechnology, CA, USA), anti-chicken GFP (1:500; GFP-1020, Aves Labs), anti-goat 5HT (1:1000; 20079, ImmunoStar, WI, USA), and anti-rabbit mCherry (1:500; ab167453, Abcam, Cambridge, UK) were used. For secondary antibodies, anti-chicken/rabbit Alexa
